Intelligence · Clinical Development
Pipeline search results
Programs matching “insulin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 62 pipeline programs matching "insulin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Alogliptin and insulin
Takeda
Diabetes Mellitus
1 trial -
CSII (Insulin Pump) plus DAFNE
United Therapeutics Europe Ltd
Type 1 Diabetes
1 trial -
Dapagliflozin 10 mg
AstraZeneca
Diabetes Mellitus, Non-Insulin-Dependent
1 trial -
Dasiglucagon 4 mg/ml
Zealand Pharma A/S
Children with congenital hyperinsulinism
1 trial -
Faster-acting insulin aspart
Novo Nordisk A/S
Diabetes
1 trial -
G-Pen
Universal Integrated
Insulin Hypoglycemia
1 trial -
G-Pen
Xeris Biopharma Holdings
Insulin Hypoglycemia
1 trial -
Human Insulin Inhalation Powder
Eli Lilly and Company
Diabetes Mellitus
1 trial -
Inhaled Human Insulin
Nektar Therapeutics UK Limited
Diabetes Mellitus, Type 2
1 trial -
Insulin Degludec and Insulin Aspart
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Diabetes
1 trial -
Insulin degludec/insulin aspart
Novo Nordisk A/S
Diabetes
1 trial -
Insulin glargine/Lixisenatide (HOE901/AVE0010)
Sanofi Pasteur
Type 2 Diabetes Mellitus
1 trial -
Insulin icodec
Novo Nordisk A/S
Diabetes, Type 2
1 trial -
Metformin on top of intensive insulin therapy
Takeda
Type 2 Diabetes Mellitus
1 trial -
TAK-559 and insulin
Takeda
Diabetes Mellitus
1 trial -
VRDN-001 (Insulin-like growth factor-1 receptor [IGF-1R] inhibitor)
Viridian Pharma Ltd
Thyroid eye disease
1 trial -
albiglutide + insulin glargine
GlaxoSmithKline
Diabetes Mellitus, Type 2
1 trial -
biphasic insulin aspart
Novo Nordisk A/S
Diabetes
1 trial -
insulin degludec
Novo Nordisk A/S
Diabetes
2 trials -
Glucagon
Xeris Biopharma Holdings
Congenital Hyperinsulinism
1 trial -
Glucagon RTU
Xeris Biopharma Holdings
Hyperinsulinemic Hypoglycemia
1 trial -
Glucagon RTU Injection With Insulin Pump Reduction
Xeris Biopharma Holdings
Hypoglycemia
1 trial -
HM-GCG-201
Alphapharm Pty Ltd
Congenital Hyperinsulinism (CHI)
1 trial -
Insulin
United Therapeutics Europe Ltd
Multiple Sclerosis, Relapsing-Remitting
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.